Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) (vol 55, 102779, 2020)Rosa De Miguel,David Rial-Crestelo,Lourdes Dominguez-Dominguez,Rocio Montejano,Andres Esteban-Cantos,Paula Aranguren-Rivas,Natalia Stella-Ascariz,Otilia Bisbal,Laura Bermejo-Plaza,Monica Garcia-Alvarez,Belen Alejos,Asuncion Hernando,Mireia Santacreu-Guerrero,Julen Cadinanos,Mario Mayoral,Juan Miguel Castro,Victoria Moreno,Luz Martin-Carbonero,Rafael Delgado,Rafael Rubio,Federico Pulido,Jose Ramon ArribasEBIOMEDICINE(2023)引用 24|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要